The tweet was deleted by the author.
But we saved everything 🙂.
Phathom Pharmaceuticals will participate in a fireside chat at the Goldman Sachs 47th Annual Global Healthcare Conference today.
The session, set for 2:40 PM EDT, offers investors and industry watchers an opportunity to hear directly from the company’s leadership about current strategies and outlook. Those unable to attend live can access a recording after the event.
Phathom has highlighted GI-focused commercial growth initiatives during a previous session at the Jefferies conference. The company also recently reflected on the legacy of founder Dr. Tachi Yamada in advancing GI medicine and patient care, as detailed in an earlier company update. Both moments offer context for Phathom’s current strategic messaging.